Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Clinical Drug Investigation
|
July 29, 2024
Pharmacokinetics and Pharmacodynamics of Nipocalimab, a Neonatal Fc Receptor Blocker, in Healthy Japanese Volunteers
Nobuko Matsushima, Sayori Shibata, Jocelyn H Leu, et al.
CNS & Neurological Disorders Drug Targets
|
February 28, 2017
Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate
Josephine D Alessandro, Kevin Garofalo, Ganlin Zhao, et al.
Plos One
|
October 17, 2015
Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®
Josephine S D'Alessandro, Jay Duffner, Joel Pradines, et al.
Glycobiology
|
April 26, 2011
Bioactivity screening of partially desulfated low-molecular-weight heparins: a structure/activity relationship study
Sucharita Roy, Hsuanchi Lai, Radouane Zouaoui, et al.
Analytical and Bioanalytical Chemistry
|
March 26, 2014
Characterization of heparin-protein interaction by saturation transfer difference (STD) NMR
Fei Yu, Sucharita Roy, Enrique Arevalo, et al.
Journal of Neurochemistry
|
May 22, 2009
Phosphorylation of the homer-binding domain of group I metabotropic glutamate receptors by cyclin-dependent kinase 5
Lianna R Orlando, Ramses Ayala, Lauren R Kett, et al.
Journal of Medicinal Chemistry
|
May 3, 2014
Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies
Sucharita Roy, Ahmed El Hadri, Sebastien Richard, et al.
Molecular & Cellular Proteomics : MCP
|
December 19, 2018
Characterization of Endogenous Human FcγRIII by Mass Spectrometry Reveals Site, Allele and Sequence Specific Glycosylation
Nathaniel Washburn, Robin Meccariello, Jay Duffner, et al.
Clinical Pharmacology and Therapeutics
|
November 8, 2018
M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study
Leona E Ling, Jan L Hillson, Renger G Tiessen, et al.
Nature Immunology
|
January 5, 2016
Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events
Olga Sobolev, Elisa Binda, Sean O'Farrell, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Clinical Drug Investigation
|
July 29, 2024
Pharmacokinetics and Pharmacodynamics of Nipocalimab, a Neonatal Fc Receptor Blocker, in Healthy Japanese Volunteers
Nobuko Matsushima, Sayori Shibata, Jocelyn H Leu, et al.
CNS & Neurological Disorders Drug Targets
|
February 28, 2017
Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate
Josephine D Alessandro, Kevin Garofalo, Ganlin Zhao, et al.
Plos One
|
October 17, 2015
Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®
Josephine S D'Alessandro, Jay Duffner, Joel Pradines, et al.
Glycobiology
|
April 26, 2011
Bioactivity screening of partially desulfated low-molecular-weight heparins: a structure/activity relationship study
Sucharita Roy, Hsuanchi Lai, Radouane Zouaoui, et al.
Analytical and Bioanalytical Chemistry
|
March 26, 2014
Characterization of heparin-protein interaction by saturation transfer difference (STD) NMR
Fei Yu, Sucharita Roy, Enrique Arevalo, et al.
Journal of Neurochemistry
|
May 22, 2009
Phosphorylation of the homer-binding domain of group I metabotropic glutamate receptors by cyclin-dependent kinase 5
Lianna R Orlando, Ramses Ayala, Lauren R Kett, et al.
Journal of Medicinal Chemistry
|
May 3, 2014
Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies
Sucharita Roy, Ahmed El Hadri, Sebastien Richard, et al.
Molecular & Cellular Proteomics : MCP
|
December 19, 2018
Characterization of Endogenous Human FcγRIII by Mass Spectrometry Reveals Site, Allele and Sequence Specific Glycosylation
Nathaniel Washburn, Robin Meccariello, Jay Duffner, et al.
Clinical Pharmacology and Therapeutics
|
November 8, 2018
M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study
Leona E Ling, Jan L Hillson, Renger G Tiessen, et al.
Nature Immunology
|
January 5, 2016
Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events
Olga Sobolev, Elisa Binda, Sean O'Farrell, et al.
Page
of 2